Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
XingpiJieyu Formula for Severe Major Depressive Disorder
NCT07590609Phase 4Completed
- Sponsor
- Peking University Sixth Hospital
- Start
- May 2023
- Primary completion
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Xingpi Jieyu Fang in major depressive disorder (MDD), sponsored by Peking University Sixth Hospital. Started May 2023; status: completed.
02
Drugs
Xingpi Jieyu Fang
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT07590609.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07590609.